Regulus Therapeutics Inc.
RGLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$46,358 | -$30,037 | -$28,323 | -$27,808 |
| Dep. & Amort. | -$1,210 | $227 | $122 | $459 |
| Deferred Tax | $0 | $0 | $0 | -$662 |
| Stock-Based Comp. | $7,735 | $2,801 | $2,177 | $2,923 |
| Change in WC | -$1,882 | $257 | $550 | $914 |
| Other Non-Cash | $42 | -$16 | -$52 | $46 |
| Operating Cash Flow | -$41,673 | -$26,768 | -$25,526 | -$24,128 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$340 | -$613 | -$361 | -$251 |
| Net Acquisitions | $0 | $3 | $15 | $0 |
| Inv. Purchases | -$83,643 | -$4,899 | -$32,759 | $0 |
| Inv. Sales/Matur. | $48,000 | $20,000 | $18,000 | $0 |
| Other Inv. Act. | $0 | $0 | -$15 | $0 |
| Investing Cash Flow | -$35,983 | $14,491 | -$15,120 | -$251 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,377 | -$3,304 | $0 | -$80 |
| Stock Issued | $93,794 | $15,120 | $4,491 | $53,791 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $0 | $0 | $26 |
| Financing Cash Flow | $92,417 | $11,816 | $4,491 | $53,737 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $14,761 | -$461 | -$36,155 | $29,358 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,829 | $24,290 | $60,445 | $31,087 |
| End Cash | $38,590 | $23,829 | $24,290 | $60,445 |
| Free Cash Flow | -$42,013 | -$27,381 | -$25,887 | -$24,379 |